Osteoarthritis
Summary
Osteoarthritis (OA) is the most common joint disease worldwide, characterised by cartilage loss, bony remodelling (osteophytes, subchondral sclerosis), synovitis, and structural joint changes. It is a major cause of pain and disability, especially in older adults. The knee, hip, hand (DIPs, CMC), and spine are most commonly affected. Management is holistic, with emphasis on exercise, weight loss, and analgesia. Joint replacement surgery offers excellent outcomes for end-stage disease.
Key Facts
- Definition: Degenerative joint disease with cartilage loss and bony changes
- Prevalence: ~10% of adults over 60 have symptomatic OA
- Risk Factors: Age, obesity, previous joint injury, female sex
- Most Commonly Affected Joints: Knee, hip, hand (DIP, PIP, 1st CMC), spine
- First-Line Treatment: Exercise, weight loss, physiotherapy
- Surgery: Joint replacement for end-stage disease
Clinical Pearls
"Activity-Related Pain": OA pain is typically worse with use ("mechanical") and better with rest. Pain at rest or at night is a red flag for inflammatory arthritis or other pathology.
X-Ray Changes Don't Correlate with Symptoms: Many people with severe radiographic OA have minimal symptoms, and vice versa. Treat the patient, not the X-ray.
Core Treatments Are Non-Pharmacological: NICE emphasises exercise, weight loss, and information/support as first-line. Medications are adjuncts, not first-line.
Why This Matters Clinically
OA is extremely prevalent and a leading cause of disability. Effective management reduces pain, improves function, and can delay or avoid surgery. Holistic, patient-centred care is key.
Incidence & Prevalence
- Symptomatic OA: ~10% of adults over 60
- Radiographic OA: ~50% of adults over 65
- Global Impact: Leading cause of disability in older adults
- Trend: Increasing due to ageing population and obesity
Demographics
| Factor | Details |
|---|---|
| Age | Increases markedly with age; rare before 40 |
| Sex | Female > Male (especially knee and hand OA); Male ~ Female (hip) |
| Obesity | Strong association especially with knee OA |
| Ethnicity | Patterns vary (e.g., hip OA less common in Asian populations) |
Risk Factors
| Risk Factor | Association |
|---|---|
| Age | Strongest risk factor |
| Obesity | Mechanical load + metabolic factors |
| Previous Joint Injury | ACL injury, meniscal injury |
| Female Sex | Especially post-menopause |
| Occupational | Kneeling, heavy lifting, repetitive tasks |
| Genetics | ~40-65% heritability in some studies |
| Muscle Weakness | Quadriceps weakness predisposes to knee OA |
| Joint Malalignment | Varus/valgus increases compartmental load |
Mechanism
Step 1: Cartilage Damage
- Imbalance between cartilage synthesis (anabolism) and breakdown (catabolism)
- Chondrocyte dysfunction
- Loss of proteoglycans and collagen
Step 2: Bony Changes
- Subchondral bone sclerosis (hardening under cartilage)
- Osteophyte (bone spur) formation at joint margins
- Subchondral cysts
Step 3: Synovitis
- Low-grade inflammation contributes to pain and progression
- Synovial thickening, effusions
Step 4: Structural Changes
- Joint space narrowing (cartilage loss)
- Capsular thickening
- Ligamentous laxity
Classification
By Joint:
- Hip OA
- Knee OA
- Hand OA (DIPs = Heberden's nodes; PIPs = Bouchard's nodes; 1st CMC = base of thumb)
- Spine (facet joint OA)
- Erosive OA (inflammatory subtype of hand OA)
By Phenotype:
- Mechanical (overload)
- Inflammatory-dominant
- Metabolic (obesity-associated)
- Post-traumatic
- Genetic
Symptoms
Typical Features:
Pattern:
Signs
Red Flags
[!CAUTION] Red Flags — Suggest Alternative Diagnosis:
- Hot, swollen, red joint with systemic features (inflammatory/septic)
- Night pain or pain at rest (malignancy, inflammatory)
- Rapid onset or progression
- Associated weight loss, fever
- Multiple joint involvement with inflammatory pattern (RA, psoriatic)
- Neurological symptoms (spinal OA with radiculopathy)
Structured Approach
Look:
- Joint swelling, deformity
- Bony enlargement
- Muscle wasting (quadriceps in knee OA)
- Gait abnormality
Feel:
- Tenderness (joint line, periarticular)
- Bony enlargement (osteophytes)
- Effusion (patellar tap, bulge sign)
- Temperature (should NOT be hot in OA)
Move:
- Range of motion (active and passive)
- Crepitus (palpable grinding with movement)
- Fixed flexion deformity
Joint-Specific Findings
| Joint | Signs |
|---|---|
| Knee | Varus/valgus deformity, crepitus, effusion, quadriceps wasting |
| Hip | Reduced internal rotation (earliest), antalgic gait |
| Hand | Heberden's nodes (DIP), Bouchard's nodes (PIP), 1st CMC squaring |
| Spine | Reduced ROM, paravertebral tenderness, radiculopathy signs |
First-Line
Diagnosis is Clinical — investigations are NOT always needed.
| Test | When | Expected Finding |
|---|---|---|
| X-ray | Diagnostic uncertainty; pre-surgery | Joint space narrowing, osteophytes, subchondral sclerosis, cysts |
| Blood Tests | To exclude inflammatory arthritis if suspected | Normal in OA (ESR, CRP, RF, anti-CCP normal) |
X-Ray Features (Mnemonic: LOSS)
- Loss of joint space
- Osteophytes
- Subchondral sclerosis
- Subchondral cysts
When to Investigate Further
| Investigation | When |
|---|---|
| MRI | If internal derangement suspected (meniscus, ligament); not routine for OA |
| Inflammatory markers + RF/Anti-CCP | If inflammatory arthritis suspected |
| Joint aspiration | To exclude septic arthritis or gout if effusion with concerning features |
Core Treatments (All Patients)
| Treatment | Details |
|---|---|
| Education | Explain condition, prognosis, self-management |
| Exercise | Strengthening (quads for knee), aerobic, ROM |
| Weight Loss | Even 5% loss reduces knee pain |
| Footwear | Supportive, shock-absorbing |
Pharmacological
| Drug | Notes |
|---|---|
| Topical NSAID | First-line for knee/hand OA; safer than oral |
| Paracetamol | Limited efficacy; use at lowest effective dose |
| Oral NSAID + PPI | Short-term, lowest effective dose; caution in elderly, CV, GI, renal disease |
| Topical Capsaicin | Alternative; local burning sensation |
| Duloxetine | For chronic pain (central sensitisation) |
Avoid:
- Opioids (limited efficacy, significant harms)
- Glucosamine/chondroitin (insufficient evidence)
Non-Pharmacological Adjuncts
- Physiotherapy
- Walking aids (stick on opposite side to affected joint)
- Knee supports, braces
- Orthotics, insoles
- TENS
- Heat/cold packs
Intra-Articular Injections
| Injection | Notes |
|---|---|
| Corticosteroid | Short-term benefit (6-8 weeks); limit frequency |
| Hyaluronic Acid | Not routinely recommended (NICE) |
Surgical
Indications:
- Severe symptoms affecting quality of life
- Failed conservative management
- Structural damage
Options:
| Procedure | When |
|---|---|
| Total Knee Replacement (TKR) | End-stage knee OA |
| Total Hip Replacement (THR) | End-stage hip OA |
| Unicompartmental Knee Replacement | Single compartment disease |
| Osteotomy | Younger patients with malalignment |
Outcomes:
- 90-95% good outcomes at 10-15 years
- Prostheses last 15-20+ years
Disease-Related
| Complication | Notes |
|---|---|
| Chronic pain | Major cause of disability |
| Reduced mobility | Falls risk, deconditioning |
| Depression | Common comorbidity |
| Muscle wasting | Quadriceps atrophy in knee OA |
Treatment-Related
| Treatment | Complication |
|---|---|
| NSAIDs | GI bleeding, CV events, renal impairment |
| Corticosteroid Injection | Infection (rare), cartilage damage (repeated), post-injection flare |
| Joint Replacement | Infection, DVT/PE, loosening, periprosthetic fracture |
Natural History
OA is a slowly progressive condition. Symptoms may fluctuate over time. Not everyone with OA will progress to needing surgery. Weight management and exercise can slow progression.
Outcomes
| Variable | Outcome |
|---|---|
| Conservative management | Many patients remain stable/improved with core treatments |
| Joint replacement | 90-95% satisfaction; 15-20+ year prosthesis survival |
Prognostic Factors
Worse Prognosis:
- Obesity
- Malalignment
- Muscle weakness
- Multiple affected joints
- Inflammatory phenotype
- Poor coping strategies
Key Guidelines
-
NICE CG177: Osteoarthritis (Care and Management) (2022) — Core treatments, stepped care approach.
-
OARSI Recommendations (2019) — International guidelines on management.
Landmark Studies
TOPKAT Trial (2020) — TKR vs non-operative treatment
- RCT comparing total knee replacement with non-operative management
- Key finding: TKR provided greater pain relief and function improvement
- Clinical Impact: Confirms benefits of TKR in appropriate patients
Evidence Strength
| Intervention | Level | Key Evidence |
|---|---|---|
| Exercise | 1a | Cochrane reviews |
| Weight loss | 1a | Meta-analyses |
| Topical NSAIDs | 1a | RCTs |
| IA corticosteroid | 1a | Short-term benefit |
| Total joint replacement | 1a | Large RCTs, registries |
What is Osteoarthritis?
Osteoarthritis (OA) is the most common type of arthritis. It happens when the cartilage that cushions your joints wears down over time, causing pain, stiffness, and sometimes swelling. It most often affects the knees, hips, hands, and spine.
Why does it matter?
OA can cause significant pain and make it harder to do everyday activities like walking, climbing stairs, or opening jars. However, with the right treatment, most people can manage their symptoms well and stay active.
How is it treated?
The most important treatments are:
-
Exercise: Strengthening and stretching exercises help support your joints and reduce pain. Walking, swimming, and cycling are good options.
-
Weight loss: Even a small amount of weight loss (5-10%) can significantly reduce knee pain if you're overweight.
-
Pain relief:
- Topical creams (anti-inflammatory gel) applied to the joint
- Paracetamol for mild pain
- Anti-inflammatory tablets (NSAIDs) for short periods if needed
-
Physiotherapy: A physiotherapist can guide you with exercises and provide walking aids if needed.
-
Injections: Steroid injections into the joint can provide temporary relief.
-
Surgery: If other treatments don't work and your quality of life is significantly affected, joint replacement surgery (hip or knee) is very effective.
What to expect
- OA is a long-term condition, but symptoms often fluctuate
- Staying active is one of the best things you can do
- Most people can manage well without surgery
- If surgery is needed, outcomes are usually excellent
When to seek help
See a doctor if:
- Pain is not improving with self-care
- You have sudden severe pain or swelling
- You notice a red, hot, swollen joint (could be infection or gout)
- Pain is stopping you from sleeping or doing daily activities
Primary Guidelines
- National Institute for Health and Care Excellence. Osteoarthritis: care and management (CG177). 2022. nice.org.uk/guidance/cg177
Key Studies
-
Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578-1589. PMID: 31278997
-
Skou ST, Roos EM, Laursen MB, et al. A Randomized, Controlled Trial of Total Knee Replacement (TOPKAT). N Engl J Med. 2015;373(17):1597-1606. PMID: 26488691
Further Resources
- Versus Arthritis: versusarthritis.org
- Arthritis Research UK: arthritisresearchuk.org
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate guidelines and specialists for patient care.